Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Influence of APOE Status on Relationship Between Cerebral Cholesterol and Agitation Severity in Alzheimer's Disease

EF 2023-24

Résumé
Alzheimer’s Disease (AD) is the most common form of dementia among older adults, altering cognition and behaviour, and causing neuropsychiatric symptoms (NPS). Agitation is a NPS that presents frequently in AD patients with moderate- to severe-dementia. It is defined as aggressive physical and/or verbal behaviours and conjunctive emotional distress. The biological mechanisms of agitation are still under investigation. 24-s-hydroxycholesterol (24-OHC) is a metabolite of cerebral cholesterol that has been reported to be associated with agitation severity. There has been no investigation on genetic influences associated with at-risk populations for AD development on 24-OHC. One marker of interest is the apolipoprotein E gene (APOE). APOE produces proteins that support transport of cholesterol in both blood and the central nervous system. There are 3 common gene variations, marked as epsilon (e)2, e3 and e4. People who carry APOE e4 from both maternal and paternal genes are 8-12 times more likely to develop AD and subsequent NPS, including agitation. This study will assess the influence of APOE e4 on the relationship between serum-based 24-OHC levels and agitation severity. Agitation severity will be scored using caregiver-directed questionnaires for agitation based on updated definitions of agitation. I propose that APOE e4 will significantly reduce the effect of 24-OHC on agitation severity when compared to other APOE gene combinations. Ultimately, the impact of agitation on quality of life for both AD patients and their caregivers must be addressed. Understanding the pathophysiological risk factors will encourage development of targeted treatments that may mitigate many of the risks seen in current options and lessen the burden of agitation in AD patient populations.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
506033
Name
Feldman Oriel
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Influence of APOE Status on Relationship Between Cerebral Cholesterol and Agitation Severity in Alzheimer's Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aging; Agitation; Alzheimer'S Disease; Biomarker; Dementia; Geriatrics; Inflammation; Memory; Neuropsychiatric Symptoms; Tnf
Abstract
Alzheimer’s Disease (AD) is the most common form of dementia among older adults, altering cognition and behaviour, and causing neuropsychiatric symptoms (NPS). Agitation is a NPS that presents frequently in AD patients with moderate- to severe-dementia. It is defined as aggressive physical and/or verbal behaviours and conjunctive emotional distress. The biological mechanisms of agitation are still under investigation. 24-s-hydroxycholesterol (24-OHC) is a metabolite of cerebral cholesterol that has been reported to be associated with agitation severity. There has been no investigation on genetic influences associated with at-risk populations for AD development on 24-OHC. One marker of interest is the apolipoprotein E gene (APOE). APOE produces proteins that support transport of cholesterol in both blood and the central nervous system. There are 3 common gene variations, marked as epsilon (e)2, e3 and e4. People who carry APOE e4 from both maternal and paternal genes are 8-12 times more likely to develop AD and subsequent NPS, including agitation. This study will assess the influence of APOE e4 on the relationship between serum-based 24-OHC levels and agitation severity. Agitation severity will be scored using caregiver-directed questionnaires for agitation based on updated definitions of agitation. I propose that APOE e4 will significantly reduce the effect of 24-OHC on agitation severity when compared to other APOE gene combinations. Ultimately, the impact of agitation on quality of life for both AD patients and their caregivers must be addressed. Understanding the pathophysiological risk factors will encourage development of targeted treatments that may mitigate many of the risks seen in current options and lessen the burden of agitation in AD patient populations.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Feldman, Oriel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~